Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

2.7.1.82: ethanolamine kinase

This is an abbreviated version!
For detailed information about ethanolamine kinase, go to the full flat file.

Word Map on EC 2.7.1.82

Reaction

ATP
+
ethanolamine
=
ADP
 +
O-Phosphoethanolamine

Synonyms

CEK4, choline/ethanolamine kinase, EKI, EKI1, ethanolamine kinase, ethanolamine kinase 1, ethanolamine kinase 2, ethanolamine phosphokinase, Etn kinase, EtnK, ETNK1, Etnk2, kinase, ethanolamine (phosphorylating), More, PfEK, Treki1

ECTree

     2 Transferases
         2.7 Transferring phosphorus-containing groups
             2.7.1 Phosphotransferases with an alcohol group as acceptor
                2.7.1.82 ethanolamine kinase

Disease

topprint

Disease on EC 2.7.1.82 - ethanolamine kinase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Cardiomyopathies
Phospholipid homeostasis and lipotoxic cardiomyopathy: A matter of balance.
Eosinophilia
Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemia.
Epilepsy
Structural mass spectrometry analysis of lipid changes in a Drosophila epilepsy model brain.
Fatty Liver
Complement C3 participates in the development of goose fatty liver potentially by regulating the expression of FASN and ETNK1.
Fetal Death
Placental thrombosis and spontaneous fetal death in mice deficient in ethanolamine kinase 2.
Infections
Kinome siRNA screen identifies novel cell-type specific dengue host target genes.
Laryngeal Neoplasms
Radioresistance in a human laryngeal squamous cell carcinoma cell line is associated with DNA methylation changes and topoisomerase II alpha.
Leukemia
Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemia.
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia.
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia.
Leukemia, Myelomonocytic, Chronic
Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemia.
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia.
Lung Neoplasms
Phospholipid dynamics in ex vivo lung cancer and normal lung explants.
Mastocytosis, Systemic
Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemia.
Neoplasm Metastasis
Hepatic metastasis of gastric cancer is associated with enhanced expression of ethanolamine kinase 2 via the p53-Bcl-2 intrinsic apoptosis pathway.
miR-199a-3p targets ETNK1 to promote invasion and migration in gastric cancer cells and is associated with poor prognosis.
Neoplasms
Ethanolamine kinase controls neuroblast divisions in Drosophila mushroom bodies.
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine.
Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression.
Hepatic metastasis of gastric cancer is associated with enhanced expression of ethanolamine kinase 2 via the p53-Bcl-2 intrinsic apoptosis pathway.
Targeting Phospholipid Metabolism in Cancer.
Primary Myelofibrosis
Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemia.
Stomach Neoplasms
Hepatic metastasis of gastric cancer is associated with enhanced expression of ethanolamine kinase 2 via the p53-Bcl-2 intrinsic apoptosis pathway.
miR-199a-3p targets ETNK1 to promote invasion and migration in gastric cancer cells and is associated with poor prognosis.
Thrombosis
Placental thrombosis and spontaneous fetal death in mice deficient in ethanolamine kinase 2.